CDK7-IN-21
CDK7-IN-21 (compound A22) is a potent CDK7 inhibitor[1].
Product Specifications
CAS Number
[2766124-39-2]
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk7-in-21.html
Purity
98.38
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C=C(F)C(NC(C=C1)=CC2=C1C(C(C=CC=C3)=C3CNC(N4N=C5)=NC(NC[C@@H]6[C@H](CNCC6)O)=NC4=C5C(C)C)=NC=C2)=O
Molecular Formula
C33H36FN9O2
Molecular Weight
609.70
References & Citations
[1]Kiyean NAM, et al. Compounds for degradation of cyclin-dependent kinase 7 (cdk7) . Patent. WO2022248682A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1250044-01 1 mg (E-Coli)
Recombinant Rickettsia peacockii NADH-quinone oxidoreductase subunit H (nuoH), partial
Ask
View Details MBS1250044-02 1 mg (Yeast)
Recombinant Rickettsia peacockii NADH-quinone oxidoreductase subunit H (nuoH), partial
Ask
View Details